Zhang Jing-Shi, Liu Feng, Conwell Christine C, Tan Yadi, Huang Leaf
Center for Pharmacogenetics, School of Pharmacy, University of Pittsburgh, PA 15213, USA.
Mol Ther. 2006 Feb;13(2):429-37. doi: 10.1016/j.ymthe.2005.08.021. Epub 2005 Oct 20.
We previously reported that sequential injection of cationic liposome and plasmid DNA leads to notably reduced inflammatory toxicity and improved transfection in the lung (Y. Tan et al., 2001, Mol. Ther. 3, 673-682). The purpose of the current study was to explore the mechanism involved in sequential injection. It was observed that sequential injection resulted in dramatically lower DNA uptake by the liver and higher DNA levels in the lung than the lipoplex injection. In vitro experiments with macrophage cells further showed that sequential addition of liposomes and DNA could diminish the cellular uptake of DNA by these cells. The contributions of serum to the enhanced bioactivity and decreased toxicity were examined by injecting mice with samples of premixed liposome with serum and then DNA (LSD sample), and the resulting activities were compared to those obtained with injection of lipoplex-serum mixtures (LDS sample). LSD yielded 80% lower TNF-alpha levels and over 10-fold higher transfection than lipoplex, which is consistent with the reported findings with sequential injection. In contrast, LDS resulted in the same TNF-alpha levels and comparable transfection with lipoplex. Thus, the results suggest that the primary interaction of serum with liposome is a critical factor contributing to the superior activity and reduced toxicity of sequential injection. Studies on the interaction between mouse serum, liposomes, and DNA showed that DNA could bind negatively charged liposome-serum complex to form a ternary complex, which has a density similar to that of the ternary complex formed between lipoplex with serum. Further in vitro tests showed that LSD and LDS were similar in particle size and protein content, but different in protein composition as observed by 2-D gel electrophoresis. In addition, DNA in LSD was more readily displaced by dextran sulfate, an anionic polymer, than in LDS. The above findings suggest that the inhibition of opsonin protein binding on the particle surface with the sequential injection may contribute to the reduced macrophage uptake and cytokine induction and that the high ability of DNA release from the particles formed after sequential injection may contribute to the improved lung gene transfection.
我们之前报道过,阳离子脂质体和质粒DNA的顺序注射可显著降低炎症毒性并改善肺部转染效果(Y. Tan等人,2001年,《分子治疗》3,673 - 682)。本研究的目的是探索顺序注射所涉及的机制。据观察,与脂质体 - DNA复合物注射相比,顺序注射导致肝脏对DNA的摄取显著降低,而肺部的DNA水平更高。对巨噬细胞进行的体外实验进一步表明,脂质体和DNA的顺序添加可减少这些细胞对DNA的摄取。通过给小鼠注射预先混合了血清的脂质体样品然后再注射DNA(LSD样品),研究了血清对增强生物活性和降低毒性的作用,并将所得活性与注射脂质体 - 血清混合物(LDS样品)所获得的活性进行比较。LSD产生的TNF - α水平比脂质体 - DNA复合物低80%,转染率高出10倍以上,这与顺序注射的报道结果一致。相比之下,LDS产生的TNF - α水平与脂质体 - DNA复合物相同,转染效果也相当。因此,结果表明血清与脂质体的主要相互作用是顺序注射具有卓越活性和降低毒性的关键因素。对小鼠血清、脂质体和DNA之间相互作用的研究表明,DNA可与带负电荷的脂质体 - 血清复合物结合形成三元复合物,其密度与脂质体 - DNA复合物与血清形成的三元复合物相似。进一步的体外测试表明,LSD和LDS在粒径和蛋白质含量方面相似,但通过二维凝胶电泳观察发现其蛋白质组成不同。此外,与LDS相比,LSD中的DNA更容易被阴离子聚合物硫酸葡聚糖取代。上述发现表明,顺序注射抑制颗粒表面调理素蛋白的结合可能有助于减少巨噬细胞摄取和细胞因子诱导,而顺序注射后形成的颗粒中DNA的高释放能力可能有助于改善肺部基因转染。